Since its founding in 2014, the American Medical Association (AMA) Opioid Task Force has sought ways that practicing physicians could play a role in helping end the epidemic. The task force’s recommendations include urging physicians to enhance their education, as well as advocate for comprehensive care for patients in pain, and for those with a substance use disorder.
Perhaps thanks in part to these efforts, more than 700,000 physicians and other health care providers took courses related to opioids in 2018. What’s more, between 2013 and 2018, the number of opioid prescriptions decreased by more than 80 million — a 33 percent decrease nationally — with every state individually decreasing opioid prescriptions over the past five years.
When it comes to helping patients with substance use disorder lead satisfying, productive lives, the science shows what works: medication prescribed by a physician or dispensed at special opioid treatment centers, combined with behavioral counseling and other services.
Despite certain positive trends and clear science, of the 20.3 million people nationwide with a substance use disorder, 90 percent receive no treatment, according to federal officials.
“The opioid crisis today is a national tragedy that requires the same resolve we have mustered for other public health epidemics. Those with substance use disorders deserve no less,” says AMA president, Dr. Patrice A. Harris. “Most people agree we need access to treatments that include medication. Unfortunately, that’s not readily available for many patients, and this epidemic will not be reversed until we deal with access issues and stigma associated with opioid misuse.”
The AMA stresses that while doctors are leading in areas where they can have an influence, they cannot end the epidemic alone. To combat the issue at the state and national level, the organization has issued a national “roadmap” to policymakers focused on these specific actions:
• Patients and physicians should have conversations about safe storage and disposal of opioids and all medications; and increase access to the opioid overdose reversal medication, naloxone, to patients at risk of overdose.
• Insurance providers should remove barriers that prevent patients from obtaining affordable medication-assisted treatment combined with counseling.
• Policymakers and regulators should enforce laws that require mental health benefits to be on par with other health benefits, thereby broadening access to treatment related to mental health and substance use disorders.
• Health insurance providers and pharmacy benefit managers should ensure patient access to affordable, non-opioid pain care.
For more info, please check out end-opioid-epidemic.org.